Latest filing published 25 Feb 2016 for Sagent Pharmaceuticals, Inc., €4,435.
Insider track record
Lorin Drake: trading record in brief
All filings by Lorin Drake on record concern Sagent Pharmaceuticals, Inc. Over a trading history stretching from 22 February 2012 to 25 February 2016, the count stands at 18 filings.
No open-market purchase appears, only 1 sale worth €18k. The rest of the record consists of 17 share grants.
On 25 February 2016 came the latest disclosure, a share grant for €4,435 in Sagent Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Lorin Drake
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 335 shares@ US$14.5821.7% of flowCommon StockSEC:0001562180-16-001814:0
- 8,214 shares0Common StockSEC:0001562180-16-001773:2
- 449 shares@ US$14.6128.9% of flowCommon StockSEC:0001562180-16-001773:0
- 335 shares@ US$13.0019.2% of flowCommon StockSEC:0001562180-16-001773:1
- 452 shares@ US$15.1630.2% of flowCommon StockSEC:0001562180-16-001732:0
- 853 sharesCommon StockSEC:0001209191-16-088448:0
- 5,480 shares0Common StockSEC:0001181431-15-005340:0
- 3,683 shares0Common StockSEC:0001181431-15-003490:0
- 449 shares@ US$28.50Common StockSEC:0001181431-15-003280:0
- 293 shares@ US$28.50Common StockSEC:0001181431-15-003280:1
- 452 shares@ US$27.22Common StockSEC:0001181431-15-002917:0
- 388 shares@ US$21.84Common StockSEC:0001181431-14-008989:0
- 290 shares@ US$21.75Common StockSEC:0001181431-14-008989:1
- 4,960 shares0Common StockSEC:0001181431-14-007821:0
- 347 shares@ US$16.85Common StockSEC:0001181431-14-000149:0
- 1,000 shares@ US$23.69Common StockSEC:0001181431-13-044503:0
- 4,924 shares0Common StockSEC:0001181431-13-012527:0
- 3,680 shares0Common StockSEC:0001181431-12-011792:0
18 of 18 declarations
